Company Filing History:
Years Active: 2018
Title: Innovations of Nicolas Coquelle in Alzheimer's Disease Treatment
Introduction
Nicolas Coquelle is an innovative inventor based in Grenoble, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating Alzheimer's disease and other forms of dementia. His work focuses on creating effective inhibitors of butyrylcholinesterase, a key enzyme involved in cognitive decline.
Latest Patents
Nicolas Coquelle holds a patent for "Disubstituted piperidines as butyrylcholinesterase inhibitors." This invention relates to new inhibitors of butyrylcholinesterase with general formulas I and II, where substituents are described in the patent description. The compounds can exist in the form of pure enantiomers or as racemic mixtures, or in the form of pharmaceutically acceptable salts. The present invention emphasizes the use of these inhibitors for the treatment of Alzheimer's disease and other forms of dementia. He has 1 patent to his name.
Career Highlights
Nicolas Coquelle is associated with the University of Ljubljana, where he continues to engage in research and development. His academic background and professional experience have equipped him with the skills necessary to innovate in the pharmaceutical sector.
Collaborations
Nicolas has collaborated with notable colleagues such as Boris Brus and Urban Kosak. Their combined expertise contributes to the advancement of research in the field of cognitive health.
Conclusion
Nicolas Coquelle's work in developing butyrylcholinesterase inhibitors represents a significant step forward in the fight against Alzheimer's disease. His innovative approach and dedication to research highlight the importance of continued exploration in this critical area of health.